Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Accenture
McKesson
Federal Trade Commission
Queensland Health
US Army

Generated: June 26, 2019

DrugPatentWatch Database Preview

Litigation Details for Novo Nordisk A/S v. Sanofi-Aventis (D. Del. 2005)

Try a free trialSee Plans and Pricing

« Back to Dashboard

Novo Nordisk A/S v. Sanofi-Aventis (D. Del. 2005)

Docket ➤ Try a Free Trial Date Filed 2005-09-02
Court District Court, D. Delaware Date Terminated 2008-09-26
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To
Parties AVENTIS PHARMA AG; AVENTIS PHARMA DEUTSCHLAND GMBH; AVENTIS PHARMACEUTICALS INC.; NOVO NORDISK A/S; SANOFI-AVENTIS
Patents 3,845,039; 5,693,027; 6,004,297
Attorneys Anne Shea Gaza; Eric R. Moran; Frederick L. Cottrell , III; Jeffrey B. Bove; John G. Day; Lauren E. Maguire; Steven J. Balick; Tiffany Geyer Lydon
Firms Novak Druce Connolly Bove Quigg LLP, the Nemours Building; Richards, Layton & Finger, PA; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Novo Nordisk A/S v. Sanofi-Aventis
The small molecule drugs covered by the patents cited in this case are ➤ Try a Free Trial , ➤ Try a Free Trial , ➤ Try a Free Trial , ➤ Try a Free Trial , ➤ Try a Free Trial , ➤ Try a Free Trial , and ➤ Try a Free Trial .

Details for Novo Nordisk A/S v. Sanofi-Aventis (D. Del. 2005)

Date Filed Document No. Description Snippet Link To Document
2006-11-15 112 Redacted Document 6,004.297 (“the ‘297 patent”l. 5.968.021 (“the ‘021 patent“l. 5,331.954 (“the ‘954 natent”l, 6.146.361… the ’408 patent is invalid 14. The claims of the ’408 patent are invalid under the Patent Laws of the…cxaminer. The ‘408 Patent 18. Since its filing, the ‘408 patent §the ‘408 patent and its tile histo;…011 patents ran in parallel Each of the ’408 and ‘011 patents claim priority to two Danish patent applications…eclaration for Patent Application and Power of Attorney forms for the ‘408 patent and the ‘011 patent list identical External link to document
2006-11-15 113 Exhibit 7 through 10 Pafellf [19] [11] Patent Numher: 6,004,297 Steenfeldt-Jenseu et a_L [45] Date of Patent: Dec. 21, 1999 […/15/2006 Page 71 of 164 U.S. Patent Du-..zl, 1999 sheet 3 afs 6,004,297 …/2006 Case 1:05-cv-00645-SLR Document 113-8 6,004,297 Shed 1 ofS Dec. 21, 1999 U.S. Pateot …cv-00645-SLR Document 113-8 Filed 11/15/2006 6,004,297 1 lNJEC'rroN sYnnvGE CROSS-RH"ERENCE…cv-00645-SLR Document 113-8 Filed 11/15/2006 6,004,297 3 -4 thatasetiniti.al rebrcmnce=has'tobeoveroome External link to document
2007-06-14 151 Redacted Document United States Patent Nos. 6,004,297 (“the ‘297 patent”), 5,968,021 (“the ‘021. patent”), 5,331,954 (“…infringement of the ’408 patent. 5. The claims of the ’408 patent are invalid under the Patent Laws of the United… the ’408 patent is invalid. 14. The claims of the ’408 patent are invalid under the Patent Laws of the… examiner The ‘408 Patent 18. Since its filing, the ‘408 patent (the ‘408 patent and its tile history…01 1 patents ran in parallel Each of the ’408 and ’011 patents claim priority to two Danish patent applications External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Accenture
AstraZeneca
US Department of Justice
Chinese Patent Office
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.